Should I decrease my insulin glargine (Lantus) dose, currently 22 units, given a blood glucose of 219 mg/dL at 2 am and 152 mg/dL at 7 am?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Do Not Decrease Your Lantus Dose

Based on your blood glucose readings (219 mg/dL at 2 AM dropping to 152 mg/dL at 7 AM), you should NOT decrease your Lantus dose—in fact, you likely need to increase it. Your fasting blood glucose of 152 mg/dL is above the recommended target of ≤100 mg/dL (5.5 mmol/L), indicating inadequate basal insulin coverage 1.

Why You Should Not Decrease

Your situation does not represent hypoglycemia or over-insulinization. Here's the clinical reasoning:

  • Your 2 AM glucose of 219 mg/dL is elevated, not low. This suggests insufficient overnight insulin coverage.
  • Your 7 AM fasting glucose of 152 mg/dL remains above target. The 2025 ADA Standards of Care recommend titrating basal insulin to achieve a fasting plasma glucose goal of ≤100 mg/dL 1.
  • The drop from 219 to 152 mg/dL represents appropriate insulin action, not dangerous hypoglycemia. This 67 mg/dL decrease over 5 hours is expected with basal insulin and does not indicate excessive dosing.

What You Should Do Instead

Increase your Lantus dose using an evidence-based titration algorithm 1:

  • Add 2 units every 3 days until your fasting blood glucose reaches ≤100 mg/dL without hypoglycemia
  • Continue this systematic increase as long as you're not experiencing blood glucose <70 mg/dL

Specific Titration Approach

The 2025 ADA guidelines provide clear dosing adjustments 1:

  • If your fasting glucose is 100-120 mg/dL: increase by 0-2 units
  • If your fasting glucose is 120-140 mg/dL: increase by 2 units
  • If your fasting glucose is 140-180 mg/dL: increase by 4 units
  • If your fasting glucose is ≥180 mg/dL: increase by 6-8 units

Given your 7 AM glucose of 152 mg/dL, you should increase your Lantus by 4 units (from 22 to 26 units).

Critical Safety Point

Only decrease basal insulin if you experience true hypoglycemia (blood glucose <70 mg/dL). The guideline is explicit: "For hypoglycemia: determine cause; if no clear reason, lower dose by 10-20%" 1. Your readings show hyperglycemia, not hypoglycemia.

Common Pitfall to Avoid

Many patients mistakenly interpret any drop in blood glucose as a sign of "too much insulin." A declining glucose trend is the desired effect of basal insulin—it only becomes problematic when glucose drops below 70 mg/dL. Your overnight decline from 219 to 152 mg/dL demonstrates that Lantus is working, but not adequately enough to reach target 2.

Monitoring Plan

  • Test your fasting blood glucose daily before making dose adjustments
  • Increase by 2-4 units every 3 days based on your fasting readings
  • Watch for blood glucose <70 mg/dL, which would signal the need to reduce the dose
  • Reassess every 3-6 months to avoid therapeutic inertia 1

Your current dose of 22 units is likely insufficient for your needs, and the evidence strongly supports upward titration rather than dose reduction.

References

Related Questions

For a patient on insulin glargine (Lantus) 18 units with an insulin‑sensitivity factor of 25 mg/dL per unit and an insulin‑to‑carbohydrate ratio of 10 g per unit, who has blood glucose readings of 234 mg/dL at 5 PM after eating 66 g of carbohydrate, 240 mg/dL at 9 PM, and 201 mg/dL at 2 AM, what should the insulin‑sensitivity factor, insulin‑to‑carbohydrate ratio, and basal Lantus dose be adjusted to?
What are the guidelines for increasing the dose of Lantus (insulin glargine)?
How should insulin glargine (Lantus) be dosed?
How should the insulin regimen be adjusted for a patient with a recent A1C of 10% who is currently on sliding‑scale insulin and insulin glargine (100 U/mL)?
Can a patient be given 30 units of insulin glargine (Lantus) at bedtime?
How does Risperdal (risperidone) decrease hypersexuality?
What is the appropriate starting dose of fluvoxamine?
Based on immunophenotypic findings of CD3‑positive T cells, CD20‑positive B cells, CD34 positivity in 1 % of cells and vessels, MPO‑positive myeloid cells, CD71‑positive erythroid precursors, CD61‑positive megakaryocytes, and a negative t(9;22) translocation, what is the diagnosis?
What is the diagnosis and appropriate management for a patient with bone marrow showing 9% blasts and dysplasia?
In a 62-year-old woman with multiple sclerosis, overactive bladder, and mixed urinary incontinence who previously developed urinary retention after an intradetrusor onabotulinumtoxinA (Botox) injection, is it safe to repeat the injection at a lower dose of 50 units?
What pre‑operative evaluation should a primary‑care physician perform for a 38‑year‑old man with a BMI of 30.44 who is taking exogenous testosterone and Wegovy (semaglutide) and has no other medical history before orthopedic surgery?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.